The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The Many Pathways of RNA Degradation
Open accessAbstract
From the earliest comparisons of RNA production with steady-state levels, it has been clear that cells transcribe more RNA than they accumulate, implying the existence of active RNA degradation systems. In general, RNA is degraded at the end of its useful life, which is long for a ribosomal RNA but very short for excised introns or spacer fragments, and is closely regulated for most mRNA species. RNA molecules with defects in processing, folding, or assembly with proteins are identified and rapidly degraded by the surveillance machinery. Because RNA degradation is ubiquitous in all cells, it is clear that it must be carefully controlled to accurately recognize target RNAs. How this is achieved is perhaps the most pressing question in the field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Global analysis of protein expression in yeast
Ghaemmaghami, S., Huh, W.-K., Bower, K., Howson, R. W., Belle, A., Dephoure, N., O'Shea, E. K., & Weissman, J. S. (2003) · Nature · doi:10.1038/nature02046 · Cited by 3,750
AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2
Vasudevan, S., & Steitz, J. A. (2007) · Cell · doi:10.1016/j.cell.2007.01.038 · Cited by 656
RNA Quality Control in Eukaryotes
Doma, M. K., & Parker, R. (2007) · Cell · doi:10.1016/j.cell.2007.10.041 · Cited by 345
Cited by
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability
Schoenmaker, L., Witzigmann, D., Kulkarni, J. A., Verbeke, R., Kersten, G., Jiskoot, W., & Crommelin, D. J. A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120586 · Cited by 1,566
Autophagy in healthy aging and disease
Aman, Y., Schmauck-Medina, T., Hansen, M., Morimoto, R. I., Simon, A. K., Bjedov, I., Palikaras, K., Simonsen, A., Johansen, T., Tavernarakis, N., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00098-4 · Cited by 1,313
Research on plant abiotic stress responses in the post‐genome era: past, present and future
Hirayama, T., & Shinozaki, K. (2010) · The Plant Journal · doi:10.1111/j.1365-313x.2010.04124.x · Cited by 1,215
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Kowalski, P. S., Rudra, A., Miao, L., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.012 · Cited by 1,127
Tools for translation: non-viral materials for therapeutic mRNA delivery
Hajj, K. A., & Whitehead, K. A. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.56 · Cited by 799
Engineered pegRNAs improve prime editing efficiency
Nelson, J. W., Randolph, P. B., Shen, S. P., Everette, K. A., Chen, P. J., Anzalone, A. V., An, M., Newby, G. A., Chen, J. C., Hsu, A., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01039-7 · Cited by 727
Opportunities and Challenges in the Delivery of mRNA-Based Vaccines
Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., & Thakur, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020102 · Cited by 584
“Moreover, mRNA is an inherently unstable molecule, which is highly prone to degradation by 5’ exonucleases, 3’ exonucleases, and endonucleases [73].”
BackgroundmRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases
Maruggi, G., Zhang, C., Li, J., Ulmer, J. B., & Yu, D. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.020 · Cited by 507
MYC: Connecting selective transcriptional control to global RNA production
Kress, T. R., Sabò, A., & Amati, B. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3984 · Cited by 521
The promise of mRNA vaccines: a biotech and industrial perspective
Jackson, N. A. C., Kester, K. E., Casimiro, D., Gurunathan, S., & DeRosa, F. (2020) · npj Vaccines · doi:10.1038/s41541-020-0159-8 · Cited by 498
“32, 33 This has been an intense area of research in the field, for which lipid nanoparticle (LNP) formulations are currently emerging as a leading category.”
BackgroundChallenges of Storage and Stability of mRNA-Based COVID-19 Vaccines
Uddin, M. N., & Roni, M. A. (2021) · Vaccines · doi:10.3390/vaccines9091033 · Cited by 371
mRNA vaccines for COVID-19: what, why and how
Park, J. W., Lagniton, P. N. P., Liu, Y., & Xu, R.-H. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59233 · Cited by 321
Yap, K., Lim, Z. Q., Khandelia, P., Friedman, B., & Makeyev, E. V. (2012) · Genes & Development · doi:10.1101/gad.188037.112 · Cited by 286
An Update on Self-Amplifying mRNA Vaccine Development
Blakney, A. K., Ip, S., & Geall, A. J. (2021) · Vaccines · doi:10.3390/vaccines9020097 · Cited by 288
The regulation of mRNA stability in mammalian cells: 2.0
Wu, X., & Brewer, G. (2012) · Gene · doi:10.1016/j.gene.2012.03.021 · Cited by 239
The Yeast Ski Complex: Crystal Structure and RNA Channeling to the Exosome Complex
Halbach, F., Reichelt, P., Rode, M., & Conti, E. (2013) · Cell · doi:10.1016/j.cell.2013.07.017 · Cited by 210
Transcriptome-wide Analysis of Exosome Targets
Schneider, C., Kudla, G., Wlotzka, W., Tuck, A., & Tollervey, D. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.013 · Cited by 195
Self-citationLAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles
Qiao, L., Hu, J., Qiu, X., Wang, C., Peng, J., Zhang, C., Zhang, M., Lu, H., & Chen, W. (2023) · Autophagy · doi:10.1080/15548627.2023.2235196 · Cited by 174
Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation
Lim, J., Kim, D., Lee, Y.-S., Ha, M., Lee, M., Yeo, J., Chang, H., Song, J., Ahn, K., & Kim, V. N. (2018) · Science · doi:10.1126/science.aam5794 · Cited by 165
Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency
Prieve, M. G., Harvie, P., Monahan, S. D., Roy, D., Li, A. G., Blevins, T. L., Paschal, A. E., Waldheim, M., Bell, E. C., Galperin, A., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.12.024 · Cited by 145
Systematic analysis of gene expression patterns associated with postmortem interval in human tissues
Zhu, Y., Wang, L., Yin, Y., & Yang, E. (2017) · Scientific Reports · doi:10.1038/s41598-017-05882-0 · Cited by 129
Matiolli, C. C., Tomaz, J. P., Duarte, G. T., Prado, F. M., Del Bem, L. E. V., Silveira, A. B., Gauer, L., Corrêa, L. G. G., Drumond, R. D., Viana, A. J. C., et al. (2011) · Plant Physiology · doi:10.1104/pp.111.181743 · Cited by 120
DeRosa, F., Smith, L., Shen, Y., Huang, Y., Pan, J., Xie, H., Yahalom, B., & Heartlein, M. W. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.03.001 · Cited by 111
Effects of Postmortem Interval on Biomolecule Integrity in the Brain
Nagy, C., Maheu, M., Lopez, J. P., Vaillancourt, K., Cruceanu, C., Gross, J. A., Arnovitz, M., Mechawar, N., & Turecki, G. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000190 · Cited by 79
RNA degradome--its biogenesis and functions
Jackowiak, P., Nowacka, M., Strozycki, P. M., & Figlerowicz, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr450 · Cited by 52
KSRP, many functions for a single protein
Briata, P. (2011) · Frontiers in Bioscience · doi:10.2741/3821 · Cited by 49
A retrovirus packages nascent host noncoding RNAs from a novel surveillance pathway
Eckwahl, M. J., Sim, S., Smith, D., Telesnitsky, A., & Wolin, S. L. (2015) · Genes & Development · doi:10.1101/gad.258731.115 · Cited by 48
Substrate specificity of the TRAMP nuclear surveillance complexes
Delan-Forino, C., Spanos, C., Rappsilber, J., & Tollervey, D. (2020) · Nature Communications · doi:10.1038/s41467-020-16965-4 · Cited by 36
Self-citationBraichenko, S., Holehouse, J., & Grima, R. (2021) · Journal of The Royal Society Interface · doi:10.1098/rsif.2021.0510 · Cited by 29
Deadenylation kinetics of mixed poly(A) tails at single-nucleotide resolution
Lee, Y.-S., Levdansky, Y., Jung, Y., Kim, V. N., & Valkov, E. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-023-01187-1 · Cited by 21
Zebrafish Ski7 tunes RNA levels during the oocyte-to-embryo transition
Cabrera-Quio, L. E., Schleiffer, A., Mechtler, K., & Pauli, A. (2021) · PLOS Genetics · doi:10.1371/journal.pgen.1009390 · Cited by 18
The simple emergence of complex molecular function
Manrubia, S. (2022) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2020.0422 · Cited by 13
Augmentation of DNA exonuclease TREX1 in macrophages as a therapy for cardiac ischemic injury
Ibrahim, A. G.-E., Ciullo, A., Komuro, H., Miyamoto, K., Jones, X. M., Yamaguchi, S., Tsi, K., Anderson, J., Godoy Coto, J., Kitka, D., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adp1338 · Cited by 12
A model explaining mRNA level fluctuations based on activity demands and RNA age
Xu, Z., & Asakawa, S. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1009188 · Cited by 9
Łabędzka-Dmoch, K., Kolondra, A., Karpińska, M. A., Dębek, S., Grochowska, J., Grochowski, M., Piątkowski, J., Hoang Diu Bui, T., & Golik, P. (2021) · RNA Biology · doi:10.1080/15476286.2021.1943929 · Cited by 8
Decoupled degradation and translation enables noise modulation by poly(A) tails
Grandi, C., Emmaneel, M., Nelissen, F. H. T., Roosenboom, L. W. M., Petrova, Y., Elzokla, O., & Hansen, M. M. K. (2024) · Cell Systems · doi:10.1016/j.cels.2024.05.004 · Cited by 8
Sterrett, M. C., Farchi, D., Strassler, S. E., Boise, L. H., Fasken, M. B., & Corbett, A. H. (2023) · G3: Genes, Genomes, Genetics · doi:10.1093/g3journal/jkad049 · Cited by 5
Metadata
- Authors
- Houseley, J., & Tollervey, D.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2009-02
- Volume
- 136
- Issue
- 4
- Pages
- 763-776
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2039357236
- Cited by
- 1,229
- References
- 4
- FWCI
- 26.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
